← Leaderboards
A Eden Evins
Massachusetts General Hospital
$20,295,171
Attributed
$31,561,005
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,561,005 · 16
By mechanism
R01$20,071,162 · 7
K12$4,172,655 · 1
K24$1,966,610 · 1
R42$1,688,473 · 1
R61$1,461,016 · 1
R21$1,280,301 · 3
Top collaborators
- Nancy A Rigotti8 shared
- Randi Melissa Schuster7 shared
- Gail L Daumit5 shared
- Maurizio Fava5 shared
- Jodi Gilman5 shared
- Melissa Culhane Maravic2 shared
- Susan Whitfield-Gabrieli1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jessica Lauren McCurley$1,033,924
- Kavitha Sarma$8,760,209
- Christopher M Celano$4,684,634
- Raul Mostoslavsky$11,553,356
- Maurizio Fava$41,478,557
Others in their field
Top investigators on “Smoking Cessation”
- Lloyd D Johnston · University Of Michigan At Ann Arbor$52,287,032
- Richard A Miech · Johns Hopkins University$46,640,555
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$38,193,270
- Ulrike Peters · Fred Hutchinson Cancer Research Center$35,830,035
- William J. Blot · Vanderbilt University$35,230,632
- Judith A James · Oklahoma Medical Research Foundation$34,326,590
Research focus
Smoking CessationDesignNicotineSmokerProgramsRandomizedAddictionNicotine DependenceAbstinenceVisitSmokingPharmaceutical PreparationsResearch PersonnelPlacebosPharmacotherapyBaseAdultParticipantTobaccoEnrollmentRelapseClinical TrialsMortality Vital StatisticsReporting
Grant awards (64)
Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness$1,461,016
R61 · FY2025 · MH · contact PI
Remote, Young Adult Lay-Counselor Delivered Behavioral and Digital Intervention for Youth to Promote Vaping Cessation and Prevent Escalation of Tobacco Use$844,926
R01 · FY2025 · CA · contact PI
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2025 · DA · contact PI
Remote, Young Adult Lay-Counselor Delivered Behavioral and Digital Intervention for Youth to Promote Vaping Cessation and Prevent Escalation of Tobacco Use$849,268
R01 · FY2024 · CA · contact PI
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2024 · DA · contact PI
Administrative Supplement: Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$163,431
R01 · FY2024 · DA
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$132,961
R01 · FY2024 · DA
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$813,497
R01 · FY2023 · DA
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers$664,845
R01 · FY2023 · DA · contact PI
Career Development Program in Substance Use and Addiction Medicine$533,472
K12 · FY2023 · DA · contact PI
Administrative Supplement: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers$166,220
R01 · FY2023 · DA · contact PI
Research Supplement to Promote Diversity in Health-Related Research: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers$62,463
R01 · FY2023 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$817,446
R01 · FY2022 · DA
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers$664,845
R01 · FY2022 · DA · contact PI
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain$785,235
R01 · FY2021 · DA
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers$669,556
R01 · FY2021 · DA · contact PI
Career Development Program in Substance Use and Addiction Medicine$538,167
K12 · FY2021 · DA
Career Development Program in Substance Use and Addiction Medicine$508,113
K12 · FY2020 · DA
Mentoring in Addiction Treatment Research$188,603
K24 · FY2020 · DA · contact PI
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2019 · DA
Advancing a novel portable detection method for cannabis intoxication$396,000
R42 · FY2019 · DA · contact PI
Advancing a novel portable detection method for cannabis intoxication$335,711
R42 · FY2019 · DA · contact PI
Mentoring in Addiction Treatment Research$188,603
K24 · FY2019 · DA · contact PI
Advancing a novel portable detection method for cannabis intoxication$731,789
R42 · FY2018 · DA
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI$659,958
R01 · FY2018 · MH
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2018 · DA
Mentoring in Addiction Treatment Research$188,603
K24 · FY2018 · DA · contact PI
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI$674,386
R01 · FY2017 · MH
Career Development Program in Substance Use and Addiction Medicine$508,653
K12 · FY2017 · DA
Advancing a novel portable detection method for cannabis intoxication$224,973
R42 · FY2017 · DA
Mentoring in Addiction Treatment Research$188,603
K24 · FY2017 · DA · contact PI
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI$664,169
R01 · FY2016 · MH
Mentoring in Addiction Treatment Research$188,603
K24 · FY2016 · DA · contact PI
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence$1,086,478
R01 · FY2015 · DA · contact PI
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI$675,958
R01 · FY2015 · MH
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence$1,179,683
R01 · FY2014 · DA · contact PI
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI$741,044
R01 · FY2014 · MH
Mentoring in Addiction Treatment Research$206,123
K24 · FY2014 · DA · contact PI
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence$1,131,580
R01 · FY2013 · DA · contact PI
Mentoring in Addiction Treatment Research$206,123
K24 · FY2013 · DA · contact PI
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence$1,215,914
R01 · FY2012 · DA · contact PI
Enhancing Self-Control of Cigarette Craving with Real-Time fMRI$213,658
R21 · FY2012 · DA · contact PI
Mentoring in Addiction Treatment Research$206,123
K24 · FY2012 · DA · contact PI
Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes$190,237
R21 · FY2012 · DA · contact PI
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence$1,277,373
R01 · FY2011 · DA · contact PI
Enhancing Self-Control of Cigarette Craving with Real-Time fMRI$277,379
R21 · FY2011 · DA · contact PI
Mentoring in Addiction Treatment Research$205,043
K24 · FY2011 · DA · contact PI
Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia$751,014
R01 · FY2010 · DA · contact PI
Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes$246,861
R21 · FY2010 · DA · contact PI
Mentoring in Addiction Treatment Research$200,183
K24 · FY2010 · DA · contact PI
Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia$753,450
R01 · FY2009 · DA · contact PI
Glycine Transport Inhibition for Nicotine Dependence in Schizophrenia$333,803
R01 · FY2009 · DA · contact PI
Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence$176,583
R21 · FY2009 · DA · contact PI
Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia$778,110
R01 · FY2008 · DA · contact PI
Glycine Transport Inhibition for Nicotine Dependence in Schizophrenia$333,803
R01 · FY2008 · DA · contact PI
Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence$175,583
R21 · FY2008 · DA · contact PI
Smoking Cessation and Smoking Relapse Prevention in Patients with Schizophrenia$812,270
R01 · FY2007 · DA · contact PI
Glycine Transport Inhibition for Nicotine Dependence in Schizophrenia$367,476
R01 · FY2006 · DA · contact PI
NICOTINE AND SMOKING CESSATION IN SCHIZOPHRENIA$177,541
K23 · FY2005 · DA
NICOTINE AND SMOKING CESSATION IN SCHIZOPHRENIA$176,877
K23 · FY2004 · DA
NICOTINE AND SMOKING CESSATION IN SCHIZOPHRENIA$172,802
K23 · FY2003 · DA
NICOTINE AND SMOKING CESSATION IN SCHIZOPHRENIA$170,644
K23 · FY2002 · DA
NICOTINE AND SMOKING CESSATION IN SCHIZOPHRENIA$166,638
K23 · FY2001 · DA
SMOKING CESSATION IN SCHIZOPHRENIA$56,286
R03 · FY2000 · DA